Structure

Physi-Chem Properties

Molecular Weight:  528.25
Volume:  548.442
LogP:  5.072
LogD:  3.166
LogS:  -4.021
# Rotatable Bonds:  4
TPSA:  86.11
# H-Bond Aceptor:  6
# H-Bond Donor:  0
# Rings:  7
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.363
Synthetic Accessibility Score:  5.501
Fsp3:  0.545
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.319
MDCK Permeability:  2.173674147343263e-05
Pgp-inhibitor:  0.996
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.019

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.186
Plasma Protein Binding (PPB):  99.06169128417969%
Volume Distribution (VD):  2.577
Pgp-substrate:  4.7971391677856445%

ADMET: Metabolism

CYP1A2-inhibitor:  0.074
CYP1A2-substrate:  0.269
CYP2C19-inhibitor:  0.603
CYP2C19-substrate:  0.753
CYP2C9-inhibitor:  0.919
CYP2C9-substrate:  0.054
CYP2D6-inhibitor:  0.665
CYP2D6-substrate:  0.078
CYP3A4-inhibitor:  0.906
CYP3A4-substrate:  0.854

ADMET: Excretion

Clearance (CL):  10.042
Half-life (T1/2):  0.156

ADMET: Toxicity

hERG Blockers:  0.249
Human Hepatotoxicity (H-HT):  0.165
Drug-inuced Liver Injury (DILI):  0.623
AMES Toxicity:  0.013
Rat Oral Acute Toxicity:  0.97
Maximum Recommended Daily Dose:  0.949
Skin Sensitization:  0.225
Carcinogencity:  0.117
Eye Corrosion:  0.023
Eye Irritation:  0.223
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC167340

Natural Product ID:  NPC167340
Common Name*:   NHRKCWIDMHBOOY-CRMKCTJSSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  NHRKCWIDMHBOOY-CRMKCTJSSA-N
Standard InCHI:  InChI=1S/C33H36O6/c1-29(2)22-17-24(38-28(36)19-9-7-6-8-10-19)32(5)21(30(22,3)14-12-23(29)34)11-15-31(4)25(20-13-16-37-18-20)26(35)27-33(31,32)39-27/h6-10,12-14,16,18,21-22,24-25,27H,11,15,17H2,1-5H3/t21-,22+,24-,25-,27-,30-,31+,32+,33-/m1/s1
SMILES:  O=C(c1ccccc1)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@@]2([C@@H]2[C@]1(C)[C@@]13O[C@@H]1C(=O)[C@H]([C@@]3(CC2)C)c1ccoc1)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1774391
PubChem CID:   52951893
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[12193038]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[1593280]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[18816111]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota fruits n.a. n.a. PMID[20669933]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota Seeds n.a. n.a. PMID[21381696]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. seed n.a. PMID[21381696]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[2607354]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[2614419]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[26339153]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota Leaves n.a. n.a. PMID[28493718]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. bark n.a. PMID[9134742]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. fruit n.a. PMID[9134742]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. leaf n.a. PMID[9134742]
NPO4406 Azadirachta indica Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 = 3100.0 nM PMID[509405]
NPT81 Cell Line A549 Homo sapiens IC50 > 20000.0 nM PMID[509405]
NPT134 Cell Line SK-BR-3 Homo sapiens IC50 > 20000.0 nM PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Ratio IC50 = 5.19 n.a. PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 1.4 % PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 56.9 % PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 3.0 % PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 38.7 % PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 4.5 % PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 28.2 % PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 15.5 % PMID[509405]
NPT116 Cell Line HL-60 Homo sapiens Activity = 51.8 % PMID[509405]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 8400.0 nM PMID[509405]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 20000.0 nM PMID[509405]
NPT27 Others Unspecified IC50 = 16100.0 nM PMID[509405]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC167340 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9379 High Similarity NPC197596
0.9157 High Similarity NPC302392
0.9048 High Similarity NPC469848
0.9036 High Similarity NPC473766
0.9036 High Similarity NPC473753
0.8951 High Similarity NPC25351
0.8902 High Similarity NPC473368
0.8788 High Similarity NPC474932
0.8743 High Similarity NPC224394
0.8743 High Similarity NPC663
0.872 High Similarity NPC469850
0.8683 High Similarity NPC471167
0.8683 High Similarity NPC471003
0.8683 High Similarity NPC471166
0.8683 High Similarity NPC470939
0.8667 High Similarity NPC60973
0.8667 High Similarity NPC209364
0.8667 High Similarity NPC107646
0.8631 High Similarity NPC476035
0.8631 High Similarity NPC475039
0.8631 High Similarity NPC14499
0.8614 High Similarity NPC472283
0.8614 High Similarity NPC286722
0.8588 High Similarity NPC478179
0.8571 High Similarity NPC6326
0.8563 High Similarity NPC473473
0.8563 High Similarity NPC475295
0.8554 High Similarity NPC41880
0.8554 High Similarity NPC104736
0.8545 High Similarity NPC471863
0.8531 High Similarity NPC247563
0.8531 High Similarity NPC105395
0.8531 High Similarity NPC242068
0.8529 High Similarity NPC478178
0.8529 High Similarity NPC475779
0.8521 High Similarity NPC469846
0.8521 High Similarity NPC471168
0.8521 High Similarity NPC472669
0.8512 High Similarity NPC305016
0.8512 High Similarity NPC287559
0.8512 High Similarity NPC475381
0.8503 High Similarity NPC81405
0.8503 High Similarity NPC304692
0.8488 Intermediate Similarity NPC88593
0.8485 Intermediate Similarity NPC246164
0.848 Intermediate Similarity NPC472282
0.848 Intermediate Similarity NPC476224
0.848 Intermediate Similarity NPC472784
0.8476 Intermediate Similarity NPC477404
0.8476 Intermediate Similarity NPC159927
0.8476 Intermediate Similarity NPC469335
0.8476 Intermediate Similarity NPC196864
0.8466 Intermediate Similarity NPC19747
0.8462 Intermediate Similarity NPC472668
0.8462 Intermediate Similarity NPC5079
0.8457 Intermediate Similarity NPC471292
0.8452 Intermediate Similarity NPC140952
0.8452 Intermediate Similarity NPC237155
0.8452 Intermediate Similarity NPC472823
0.8452 Intermediate Similarity NPC474611
0.8443 Intermediate Similarity NPC204663
0.8443 Intermediate Similarity NPC263265
0.8439 Intermediate Similarity NPC475237
0.8439 Intermediate Similarity NPC475641
0.843 Intermediate Similarity NPC160651
0.843 Intermediate Similarity NPC327922
0.843 Intermediate Similarity NPC296558
0.8424 Intermediate Similarity NPC272590
0.8421 Intermediate Similarity NPC121995
0.8412 Intermediate Similarity NPC51568
0.8412 Intermediate Similarity NPC234660
0.8412 Intermediate Similarity NPC476197
0.8405 Intermediate Similarity NPC224418
0.8402 Intermediate Similarity NPC335761
0.8402 Intermediate Similarity NPC333139
0.8402 Intermediate Similarity NPC191828
0.8402 Intermediate Similarity NPC25255
0.8393 Intermediate Similarity NPC195131
0.8383 Intermediate Similarity NPC75310
0.8382 Intermediate Similarity NPC470995
0.8372 Intermediate Similarity NPC270312
0.8372 Intermediate Similarity NPC476850
0.8372 Intermediate Similarity NPC173516
0.8372 Intermediate Similarity NPC476861
0.8364 Intermediate Similarity NPC156189
0.8364 Intermediate Similarity NPC212257
0.8363 Intermediate Similarity NPC56358
0.8363 Intermediate Similarity NPC472664
0.8363 Intermediate Similarity NPC476856
0.8363 Intermediate Similarity NPC61967
0.8363 Intermediate Similarity NPC261184
0.8363 Intermediate Similarity NPC27541
0.8363 Intermediate Similarity NPC126984
0.8363 Intermediate Similarity NPC62692
0.8363 Intermediate Similarity NPC476858
0.8363 Intermediate Similarity NPC476857
0.8363 Intermediate Similarity NPC469849
0.8363 Intermediate Similarity NPC123088
0.8363 Intermediate Similarity NPC276735
0.8353 Intermediate Similarity NPC18986
0.8353 Intermediate Similarity NPC68848
0.8353 Intermediate Similarity NPC193798
0.8352 Intermediate Similarity NPC478177
0.8344 Intermediate Similarity NPC233763
0.8344 Intermediate Similarity NPC62799
0.8333 Intermediate Similarity NPC126723
0.8333 Intermediate Similarity NPC285227
0.8333 Intermediate Similarity NPC238843
0.8333 Intermediate Similarity NPC199044
0.8333 Intermediate Similarity NPC175964
0.8333 Intermediate Similarity NPC471169
0.8324 Intermediate Similarity NPC471397
0.8324 Intermediate Similarity NPC242334
0.8324 Intermediate Similarity NPC186746
0.8323 Intermediate Similarity NPC178932
0.8314 Intermediate Similarity NPC470875
0.8314 Intermediate Similarity NPC149945
0.8304 Intermediate Similarity NPC165218
0.8304 Intermediate Similarity NPC283209
0.8304 Intermediate Similarity NPC292389
0.8304 Intermediate Similarity NPC472780
0.8304 Intermediate Similarity NPC134254
0.8304 Intermediate Similarity NPC39986
0.8304 Intermediate Similarity NPC469338
0.8304 Intermediate Similarity NPC472783
0.8304 Intermediate Similarity NPC302369
0.8304 Intermediate Similarity NPC285567
0.8303 Intermediate Similarity NPC470790
0.8303 Intermediate Similarity NPC470791
0.8294 Intermediate Similarity NPC8389
0.8294 Intermediate Similarity NPC472653
0.8293 Intermediate Similarity NPC221809
0.8293 Intermediate Similarity NPC71821
0.8284 Intermediate Similarity NPC7059
0.8284 Intermediate Similarity NPC469847
0.8276 Intermediate Similarity NPC44602
0.8274 Intermediate Similarity NPC471175
0.8274 Intermediate Similarity NPC469336
0.8274 Intermediate Similarity NPC472785
0.8266 Intermediate Similarity NPC476853
0.8263 Intermediate Similarity NPC475777
0.8263 Intermediate Similarity NPC75906
0.8256 Intermediate Similarity NPC470940
0.8256 Intermediate Similarity NPC276551
0.8256 Intermediate Similarity NPC476860
0.8249 Intermediate Similarity NPC472665
0.8246 Intermediate Similarity NPC79571
0.8246 Intermediate Similarity NPC188649
0.8246 Intermediate Similarity NPC329938
0.8246 Intermediate Similarity NPC69028
0.8246 Intermediate Similarity NPC472781
0.8246 Intermediate Similarity NPC472767
0.8246 Intermediate Similarity NPC472782
0.8239 Intermediate Similarity NPC471437
0.8239 Intermediate Similarity NPC94763
0.8239 Intermediate Similarity NPC236004
0.8235 Intermediate Similarity NPC477403
0.8232 Intermediate Similarity NPC262198
0.8229 Intermediate Similarity NPC159232
0.8229 Intermediate Similarity NPC294512
0.8218 Intermediate Similarity NPC271235
0.8214 Intermediate Similarity NPC114880
0.8208 Intermediate Similarity NPC23387
0.8208 Intermediate Similarity NPC277618
0.8204 Intermediate Similarity NPC18135
0.8202 Intermediate Similarity NPC295914
0.8198 Intermediate Similarity NPC477405
0.8198 Intermediate Similarity NPC88841
0.8198 Intermediate Similarity NPC288602
0.8193 Intermediate Similarity NPC472654
0.8193 Intermediate Similarity NPC192069
0.8193 Intermediate Similarity NPC329180
0.8193 Intermediate Similarity NPC211625
0.8192 Intermediate Similarity NPC176413
0.8192 Intermediate Similarity NPC56953
0.8192 Intermediate Similarity NPC469633
0.8176 Intermediate Similarity NPC195954
0.8176 Intermediate Similarity NPC167142
0.8176 Intermediate Similarity NPC88007
0.8176 Intermediate Similarity NPC249021
0.8176 Intermediate Similarity NPC194499
0.8171 Intermediate Similarity NPC245522
0.8171 Intermediate Similarity NPC56731
0.8171 Intermediate Similarity NPC114513
0.8171 Intermediate Similarity NPC118086
0.8171 Intermediate Similarity NPC472659
0.8166 Intermediate Similarity NPC472786
0.8166 Intermediate Similarity NPC92979
0.8161 Intermediate Similarity NPC310572
0.8144 Intermediate Similarity NPC476122
0.8144 Intermediate Similarity NPC46551
0.814 Intermediate Similarity NPC263432
0.814 Intermediate Similarity NPC290400
0.814 Intermediate Similarity NPC96443
0.814 Intermediate Similarity NPC117986
0.8136 Intermediate Similarity NPC469576
0.8136 Intermediate Similarity NPC471632
0.8129 Intermediate Similarity NPC116639
0.8114 Intermediate Similarity NPC472652
0.8111 Intermediate Similarity NPC254588

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC167340 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8402 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.8371 Intermediate Similarity NPD8434 Phase 2
0.8274 Intermediate Similarity NPD5761 Phase 2
0.8274 Intermediate Similarity NPD5760 Phase 2
0.8192 Intermediate Similarity NPD6765 Approved
0.8192 Intermediate Similarity NPD6764 Approved
0.8011 Intermediate Similarity NPD6785 Approved
0.8011 Intermediate Similarity NPD6784 Approved
0.7805 Intermediate Similarity NPD1471 Phase 3
0.7784 Intermediate Similarity NPD7236 Approved
0.7667 Intermediate Similarity NPD7799 Discontinued
0.7558 Intermediate Similarity NPD7239 Suspended
0.7544 Intermediate Similarity NPD6273 Approved
0.7473 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7433 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD3226 Approved
0.7399 Intermediate Similarity NPD920 Approved
0.7371 Intermediate Similarity NPD6599 Discontinued
0.7345 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7819 Suspended
0.7303 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD1247 Approved
0.7283 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD919 Approved
0.724 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD5494 Approved
0.7232 Intermediate Similarity NPD7411 Suspended
0.7222 Intermediate Similarity NPD3749 Approved
0.7222 Intermediate Similarity NPD7075 Discontinued
0.722 Intermediate Similarity NPD8404 Phase 2
0.7198 Intermediate Similarity NPD8127 Discontinued
0.7184 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD8032 Phase 2
0.7168 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD7057 Phase 3
0.7167 Intermediate Similarity NPD7058 Phase 2
0.7151 Intermediate Similarity NPD4628 Phase 3
0.7128 Intermediate Similarity NPD7685 Pre-registration
0.7126 Intermediate Similarity NPD6799 Approved
0.7118 Intermediate Similarity NPD2796 Approved
0.7107 Intermediate Similarity NPD8285 Discontinued
0.7097 Intermediate Similarity NPD3751 Discontinued
0.7095 Intermediate Similarity NPD6801 Discontinued
0.7081 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD6808 Phase 2
0.7059 Intermediate Similarity NPD3748 Approved
0.7017 Intermediate Similarity NPD5402 Approved
0.7017 Intermediate Similarity NPD3817 Phase 2
0.6994 Remote Similarity NPD1243 Approved
0.6989 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6978 Remote Similarity NPD7768 Phase 2
0.6977 Remote Similarity NPD5762 Approved
0.6977 Remote Similarity NPD2346 Discontinued
0.6977 Remote Similarity NPD5763 Approved
0.6963 Remote Similarity NPD8312 Approved
0.6963 Remote Similarity NPD8313 Approved
0.6959 Remote Similarity NPD2799 Discontinued
0.6952 Remote Similarity NPD7473 Discontinued
0.6947 Remote Similarity NPD6559 Discontinued
0.6943 Remote Similarity NPD8150 Discontinued
0.6935 Remote Similarity NPD3926 Phase 2
0.6935 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6927 Remote Similarity NPD7458 Discontinued
0.691 Remote Similarity NPD5403 Approved
0.6893 Remote Similarity NPD5401 Approved
0.6886 Remote Similarity NPD6832 Phase 2
0.6885 Remote Similarity NPD3882 Suspended
0.6882 Remote Similarity NPD6355 Discontinued
0.6882 Remote Similarity NPD3787 Discontinued
0.6881 Remote Similarity NPD7497 Discontinued
0.6879 Remote Similarity NPD6004 Phase 3
0.6879 Remote Similarity NPD2344 Approved
0.6879 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6002 Phase 3
0.6879 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6879 Remote Similarity NPD6005 Phase 3
0.6878 Remote Similarity NPD5844 Phase 1
0.6878 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6864 Remote Similarity NPD7961 Discontinued
0.686 Remote Similarity NPD7033 Discontinued
0.6857 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6857 Remote Similarity NPD3750 Approved
0.6848 Remote Similarity NPD1876 Approved
0.6833 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6828 Remote Similarity NPD6959 Discontinued
0.6824 Remote Similarity NPD4140 Approved
0.6818 Remote Similarity NPD3887 Approved
0.6816 Remote Similarity NPD4107 Approved
0.681 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6807 Remote Similarity NPD3267 Approved
0.6807 Remote Similarity NPD3266 Approved
0.6805 Remote Similarity NPD2313 Discontinued
0.6798 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6798 Remote Similarity NPD7435 Discontinued
0.6798 Remote Similarity NPD2534 Approved
0.6798 Remote Similarity NPD2532 Approved
0.6798 Remote Similarity NPD2533 Approved
0.6796 Remote Similarity NPD7028 Phase 2
0.6793 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6791 Remote Similarity NPD6232 Discontinued
0.6788 Remote Similarity NPD5327 Phase 3
0.6786 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6776 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6761 Remote Similarity NPD7003 Approved
0.6753 Remote Similarity NPD8407 Phase 2
0.6748 Remote Similarity NPD17 Approved
0.6743 Remote Similarity NPD1549 Phase 2
0.6739 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6738 Remote Similarity NPD7199 Phase 2
0.6727 Remote Similarity NPD3972 Approved
0.6724 Remote Similarity NPD1551 Phase 2
0.6723 Remote Similarity NPD2309 Approved
0.6722 Remote Similarity NPD6980 Clinical (unspecified phase)
0.672 Remote Similarity NPD2403 Approved
0.672 Remote Similarity NPD6168 Clinical (unspecified phase)
0.672 Remote Similarity NPD6166 Phase 2
0.672 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6719 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6706 Remote Similarity NPD3268 Approved
0.6706 Remote Similarity NPD3764 Approved
0.6705 Remote Similarity NPD2800 Approved
0.6703 Remote Similarity NPD4380 Phase 2
0.6702 Remote Similarity NPD7229 Phase 3
0.6701 Remote Similarity NPD8435 Approved
0.67 Remote Similarity NPD4482 Phase 3
0.6686 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6686 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6686 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6684 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6684 Remote Similarity NPD8368 Discontinued
0.6683 Remote Similarity NPD7874 Approved
0.6683 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6663 Approved
0.6667 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6649 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6649 Remote Similarity NPD7808 Phase 3
0.6649 Remote Similarity NPD3818 Discontinued
0.6647 Remote Similarity NPD6353 Approved
0.6647 Remote Similarity NPD7095 Approved
0.6634 Remote Similarity NPD7698 Approved
0.6634 Remote Similarity NPD7697 Approved
0.6634 Remote Similarity NPD7696 Phase 3
0.6632 Remote Similarity NPD7784 Clinical (unspecified phase)
0.663 Remote Similarity NPD6280 Approved
0.663 Remote Similarity NPD6279 Approved
0.663 Remote Similarity NPD1934 Approved
0.6629 Remote Similarity NPD6100 Approved
0.6629 Remote Similarity NPD2935 Discontinued
0.6629 Remote Similarity NPD6099 Approved
0.6628 Remote Similarity NPD4307 Phase 2
0.6627 Remote Similarity NPD1608 Approved
0.6616 Remote Similarity NPD8360 Approved
0.6616 Remote Similarity NPD8361 Approved
0.6613 Remote Similarity NPD4966 Approved
0.6613 Remote Similarity NPD4965 Approved
0.6613 Remote Similarity NPD4967 Phase 2
0.6608 Remote Similarity NPD6798 Discontinued
0.6608 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6602 Remote Similarity NPD7871 Phase 2
0.6602 Remote Similarity NPD7870 Phase 2
0.6602 Remote Similarity NPD8319 Approved
0.6602 Remote Similarity NPD8320 Phase 1
0.6598 Remote Similarity NPD7251 Discontinued
0.6591 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6591 Remote Similarity NPD2353 Approved
0.659 Remote Similarity NPD5735 Approved
0.6585 Remote Similarity NPD5585 Approved
0.6576 Remote Similarity NPD5890 Approved
0.6576 Remote Similarity NPD5889 Approved
0.6575 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6573 Remote Similarity NPD8166 Discontinued
0.6571 Remote Similarity NPD1510 Phase 2
0.657 Remote Similarity NPD6233 Phase 2
0.6569 Remote Similarity NPD6777 Approved
0.6569 Remote Similarity NPD6781 Approved
0.6569 Remote Similarity NPD6776 Approved
0.6569 Remote Similarity NPD6779 Approved
0.6569 Remote Similarity NPD6780 Approved
0.6569 Remote Similarity NPD6782 Approved
0.6569 Remote Similarity NPD6778 Approved
0.6568 Remote Similarity NPD2798 Approved
0.6562 Remote Similarity NPD7177 Discontinued
0.6556 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6554 Remote Similarity NPD970 Clinical (unspecified phase)
0.6546 Remote Similarity NPD6797 Phase 2
0.6545 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6543 Remote Similarity NPD6234 Discontinued
0.6541 Remote Similarity NPD37 Approved
0.6532 Remote Similarity NPD2979 Phase 3
0.6532 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6529 Remote Similarity NPD5736 Approved
0.6528 Remote Similarity NPD7907 Approved
0.6522 Remote Similarity NPD6585 Discontinued
0.6514 Remote Similarity NPD7097 Phase 1
0.6509 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6507 Remote Similarity NPD7701 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data